Paul Denslow
Amministratore Delegato presso Intus Biosciences LLC
Profilo
Paul Denslow currently works as the Chief Executive Officer & Director at Intus Biosciences LLC.
He has also worked as the Head-Forex Sales at Standard Chartered Bank (New York Branch) from 2014 to present.
Posizioni attive di Paul Denslow
| Società | Posizione | Inizio |
|---|---|---|
Standard Chartered Bank (New York Branch)
 Standard Chartered Bank (New York Branch) Regional BanksFinance Standard Chartered Bank (New York) provides commercial banking services. Its products and services include cash management, foreign exchange and treasury products, commodity finance, and structured import and export finance services. The company was founded in 1902 and is headquartered in New York, NY. | Vendite & Marketing | 29/07/2014 |
Intus Biosciences LLC
 Intus Biosciences LLC Medical/Nursing ServicesHealth Services Intus Biosciences LLC provides the first rapid and cost-effective method for looking at the micro-biome at sufficient resolution to use as a diagnostic test. The company was founded by Mark Driscoll and Thomas Jarvie in 2015 and is headquartered in Farmington, CT. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Standard Chartered Bank (New York Branch)
Standard Chartered Bank (New York Branch) Regional BanksFinance Standard Chartered Bank (New York) provides commercial banking services. Its products and services include cash management, foreign exchange and treasury products, commodity finance, and structured import and export finance services. The company was founded in 1902 and is headquartered in New York, NY. | Finance |
Intus Biosciences LLC
Intus Biosciences LLC Medical/Nursing ServicesHealth Services Intus Biosciences LLC provides the first rapid and cost-effective method for looking at the micro-biome at sufficient resolution to use as a diagnostic test. The company was founded by Mark Driscoll and Thomas Jarvie in 2015 and is headquartered in Farmington, CT. | Health Services |
- Borsa valori
- Insiders
- Paul Denslow